title: Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.
abstract: Complicated urinary tract infection is a challenging infection, since cure is difficult and either persistence or recurrence is common. The challenge is frequently increased because complicated urinary tract infection is often caused by gram-negative bacilli resistant to multiple antimicrobial drugs. In this review, we approach the therapy of complicated urinary tract infection with an emphasis on those caused by antimicrobial drug-resistant gram-negative uropathogens.
authors: Drexel University School of Public Health, Philadelphia, PA, USA, ml46@drexel.edu.
authors: Matthew E
authors: ME
authors: Levison
authors: Donald
authors: D
authors: Kaye
references: Lancet Infect Dis. 2010 Sep;10(9):597-602
references: 20705517
references: J Antimicrob Chemother. 2010 May;65(5):1019-27
references: 20299494
references: Curr Infect Dis Rep. 2008 Nov;10(6):499-504
references: 18945392
references: MMWR Morb Mortal Wkly Rep. 2012 Jun 22;61(24):446-8
references: 22717513
references: Pharmacotherapy. 2011 Sep;31(9):912-21
references: 21923592
references: Clin Infect Dis. 2010 Aug 1;51(3):286-94
references: 20572763
references: J Infect. 2009 Feb;58(2):91-102
references: 19195714
references: Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents
references: 11585791
references: J Antimicrob Chemother. 2004 May;53(5):837-40
references: 15044428
references: Clin Microbiol Infect. 2000 Sep;6(9):460-3
references: 11168179
references: BMC Med. 2010 May 26;8:30
references: 20504298
references: J Antimicrob Chemother. 1995 Jun;35(6):765-73
references: 7559188
references: Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7
references: 16723596
references: Clin Infect Dis. 2004 Sep 1;39(5):665-6
references: 15356780
references: J Antimicrob Chemother. 2010 Sep;65(9):1862-77
references: 20587612
references: Antimicrob Agents Chemother. 2012 Jun;56(6):3432-4
references: 22450982
references: Clin Infect Dis. 2011 Nov;53(9):879-84
references: 21900484
references: Lancet Infect Dis. 2009 Apr;9(4):228-36
references: 19324295
references: Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
references: 17630334
references: Lancet Infect Dis. 2011 May;11(5):355-62
references: 21478057
references: Arzneimittelforschung. 2005;55(7):420-7
references: 16080282
references: J Antimicrob Chemother. 2008 Nov;62(5):895-904
references: 18676620
references: JAMA. 1976 Apr 26;235(17):1854-6
references: 946486
references: J Clin Microbiol. 2008 May;46(5):1892-3
references: 18460636
references: Clin Infect Dis. 2011 Mar 1;52(5):e103-20
references: 21292654
references: Lancet. 1994 Nov 12;344(8933):1329-32
references: 7968028
references: Antimicrob Agents Chemother. 1999 Jul;43(7):1669-73
references: 10390220
references: Can J Infect Dis Med Microbiol. 2005 Nov;16(6):349-60
references: 18159518
references: Clin Infect Dis. 1999 Aug;29(2):352-5
references: 10476741
references: J Antimicrob Chemother. 2010 Nov;65 Suppl 3:iii25-33
references: 20876625
references: Antimicrob Agents Chemother. 2012 Jun;56(6):3043-6
references: 22391544
references: Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1699-704
references: 22052606
references: J Infect. 2011 Feb;62(2):159-64
references: 21055417
references: Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10
references: 18154533
references: Clin Infect Dis. 2012 Jun;54(12):1699-709
references: 22467668
references: Int J Antimicrob Agents. 2010 Apr;35(4):316-21
references: 20060273
references: MMWR Morb Mortal Wkly Rep. 2009 Mar 20;58(10):256-60
references: 19300408
references: Lancet Infect Dis. 2010 Jan;10(1):43-50
references: 20129148